Molecular Instruments Segment Shows Strong Market Adoption

By Author: Shreya
Total Articles: 19
Comment this article

Meticulous Research®—a leading market research company, published a research report titled, ‘Middle East & Africa Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software) Test Type (Lab, PoC) Technology (PCR, ISH, INAAT, Sequencing, Microarray) Application (Influenza, HPV, Oncology, Gene Testing) End User - Forecast to 2032’
According to this latest publication from Meticulous Research®, the Middle East & Africa Molecular Diagnostics Market is growing steadily. By 2032, it could reach $1.16 billion. Every year, about 5.4% growth is expected from 2025. Rising disease rates are one reason for this growth. Both infectious and chronic conditions are increasing. That makes Molecular Diagnostics more important than ever. Hospitals and clinics are updating their Molecular Laboratories. They are using PCR tests and other Molecular Tests to detect illnesses quickly. Molecular Testing helps doctors make faster, more accurate decisions. MDx tools are also helping tailor treatments to individual patients, especially in cancer care. Healthcare spending is rising across the region. Governments and ...
... private investors are funding modern diagnostic centers. In the UAE, medical and wellness tourism is adding to the demand. Many international patients come looking for advanced Molecular Testing services. The market does have challenges. Molecular Tests can be expensive. Rules and regulations differ from one country to another. This slows down adoption. Many regions also face a shortage of skilled lab professionals. Still, opportunities are emerging. Companion diagnostics are becoming popular. Point-of-care MDx devices make testing faster and more accessible. As awareness grows, the market is likely to expand steadily in both public and private healthcare sectors.

Key Players

The key players profiled in the Middle East & Africa molecular diagnostics market report are AstraGene LLC (U.A.E.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Illumina, Inc. (U.S.), AstraZeneca Gulf FZ LLC (Dubai), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Abbott Laboratories (U.S), and Agilent Technologies, Inc. (U.S.).
The Middle East & Africa molecular diagnostics market is segmented by Offering (Kits & Reagents, Instruments, Software & Services), Test Type (Laboratory Tests and Point-of-Care [POC] Tests), Technology (Polymerase Chain Reaction [PCR], In Situ Hybridization [ISH], Isothermal Nucleic Acid Amplification Technology [INAAT], Microarrays, Sequencing, Mass Spectrometry, and Other Technologies), Application (Infectious Diseases [Respiratory Diseases, Hepatitis, HIV, Chlamydia Trachomatis/Neisseria Gonorrhoeae, Human Papillomavirus {HPV}, Healthcare-Associated Infections {HAIs}, and Other Infectious Diseases], Oncology [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Lymphoma, Leukemia, Cervical Cancer, and Other Cancer Types], Genetic Testing, Neurological Diseases, Cardiovascular Diseases, and Other Applications), End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Other End Users), and geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Molecular Instruments Segment Gains Traction in Middle East & Africa Market

The kits and reagents segment will likely have the biggest share of the Middle East & Africa Molecular Diagnostics Market in 2025. This is due to the availability of many Molecular Diagnostics tools and growing interest in early disease detection. In September 2024, WHO Africa, supported by F. Hoffmann-La Roche, started a program in Cote d’Ivoire, Kenya, and Zimbabwe. The program promotes health awareness and provides Molecular Testing for breast and cervical cancer. Molecular Laboratories are equipped with PCR and other Molecular Tests to ensure precise results. Initiatives like this demonstrate the importance of MDx and modern molecular tools in improving patient care.
Expansion of Molecular Laboratories Drives Growth in Laboratory Testing
In 2025, laboratory tests are expected to make up the largest part of the Middle East & Africa Molecular Diagnostics Market. Hospitals and Molecular Laboratories conduct many tests because they provide highly accurate results. The growth of lab networks across the region also helps expand this segment. A good example is 54gene in Nigeria. In December 2021, they opened a chain of labs called 7RiverLabs. These labs use modern Molecular Testing equipment, including PCR and other Molecular Tests, to deliver fast and reliable results. They also provide affordable MDx solutions for both patients and healthcare providers. Efforts like this show how Molecular Laboratories and laboratory testing are becoming central to early disease detection and improved patient care in the region.

Growth of PCR Testing Drives Molecular Diagnostics Market Expansion

In 2025, PCR tests are expected to take the lead in the Middle East & Africa Molecular Diagnostics Market. They are highly accurate and reliable. That is why so many hospitals and Molecular Laboratories use them. The COVID-19 pandemic made labs adopt new Molecular Tests faster. In February 2022, F. Hoffmann-La Roche Ltd. launched the cobas 5800 system in CE-marked countries. This included the cobas SARS-CoV-2 Qualitative test and the cobas SARS-CoV-2 & Influenza A/B test. These tests let labs handle low, medium, and high testing volumes efficiently. They also make Molecular Testing and MDx solutions more accessible to patients. Initiatives like this show how Molecular Laboratories are improving early diagnosis and patient care across the region.

Rising Infections Drive Demand for Molecular Testing in Middle East & Africa

In 2025, infectious diseases are likely to make up the largest part of the Middle East & Africa Molecular Diagnostics Market. The number of infections is rising. And more money is being spent on new diagnostic tools. For example, the World Health Organization (WHO) said there were 249 million malaria cases worldwide in 2022. Africa had 94% of them. That shows how big the need is for quick and reliable Molecular Tests. Hospitals and Molecular Laboratories are using PCR and other Molecular Testing methods more often. MDx solutions help doctors get accurate results. They also make it easier to treat patients early and stop infections from spreading.

Expansion of Hospitals Drives Molecular Testing Demand in the Region

In 2025, hospitals and clinics are expected to lead the Middle East & Africa Molecular Diagnostics Market. More people are being admitted for diseases that need Molecular Tests. And more hospitals are opening in emerging countries. That’s boosting demand for Molecular Diagnostics. For example, in April 2024, Burjeel Holdings in the UAE teamed up with OncoHelix, Inc. (U.S.) to open a new Molecular Laboratory in Abu Dhabi. The lab provides advanced Molecular Testing, including PCR, cellular, and immunological profile tests. MDx solutions make it easier for patients to get fast and accurate results. These efforts show how hospitals and clinics are improving care. And how modern Molecular Laboratories are helping doctors detect diseases earlier across the region.

PCR and MDx Solutions Drive Regional Molecular Testing Growth

In 2025, Saudi Arabia is expected to take the lead in the Middle East & Africa Molecular Diagnostics Market. The country has a high number of both infectious and chronic diseases. And hospitals and Molecular Laboratories are using Molecular Diagnostics more than ever. Healthcare infrastructure is improving. Spending on health is also increasing. Many labs now use PCR and other Molecular Testing methods. MDx solutions help doctors give more precise, personalized care. These changes explain why Saudi Arabia is at the forefront of molecular diagnostics in the region.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5791

Key questions answered in the report:

Which factors are driving the growth of the Middle East & Africa Molecular Diagnostics Market?
How is medical and wellness tourism influencing demand for molecular diagnostics?
What factors are contributing to the growth of the kits and reagents segment?
How are initiatives like the WHO-supported program in Cote d’Ivoire, Kenya, and Zimbabwe impacting molecular testing adoption?
How are laboratory networks expanding to support the growth of laboratory tests?
What role do affordable MDx solutions play in laboratory testing across the region?
What are some examples of new PCR products launched to meet rising testing demands?
How do PCR and other molecular tests improve early diagnosis and patient care?
How is the expansion of hospitals and clinics in emerging countries affecting demand?
Can you provide examples of hospitals or clinics partnering to establish advanced molecular laboratories?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research